Edesa Biotech Inc

Research Edesa Biotech Inc (EDSA) on Bullrun: market cap USD 68.15M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEDSA
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 68.15M
• Financial periodFY2025
• Net income-USD 7.19M

Valuation Snapshot

latest market cap is USD 68.15M.

About Edesa Biotech Inc

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome;

Frequently asked questions

What is Edesa Biotech Inc's market cap?

Edesa Biotech Inc's market capitalization is USD 68.15M.

What does Edesa Biotech Inc do?

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.